Literature DB >> 35761107

Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.

Aline Azabdaftari1, Kelsey D J Jones2,3, Jochen Kammermeier4, Holm H Uhlig5,6,7.   

Abstract

Over 100 genes are associated with monogenic forms of inflammatory bowel disease (IBD). These genes affect the epithelial barrier function, innate and adaptive immunity in the intestine, and immune tolerance. We provide an overview of newly discovered monogenic IBD genes and illustrate how a recently proposed taxonomy model can integrate phenotypes and shared pathways. We discuss how functional understanding of genetic disorders and clinical genomics supports personalised medicine for patients with monogenic IBD.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Year:  2022        PMID: 35761107     DOI: 10.1007/s00439-022-02464-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  90 in total

1.  Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.

Authors:  Yaron Avitzur; Conghui Guo; Lucas A Mastropaolo; Ehsan Bahrami; Hannah Chen; Zhen Zhao; Abdul Elkadri; Sandeep Dhillon; Ryan Murchie; Ramzi Fattouh; Hien Huynh; Jennifer L Walker; Paul W Wales; Ernest Cutz; Yoichi Kakuta; Joel Dudley; Jochen Kammermeier; Fiona Powrie; Neil Shah; Christoph Walz; Michaela Nathrath; Daniel Kotlarz; Jacek Puchaka; Jonathan R Krieger; Tomas Racek; Thomas Kirchner; Thomas D Walters; John H Brumell; Anne M Griffiths; Nima Rezaei; Parisa Rashtian; Mehri Najafi; Maryam Monajemzadeh; Stephen Pelsue; Dermot P B McGovern; Holm H Uhlig; Eric Schadt; Christoph Klein; Scott B Snapper; Aleixo M Muise
Journal:  Gastroenterology       Date:  2014-01-11       Impact factor: 22.682

2.  Gastrointestinal manifestations of chronic granulomatous disease.

Authors:  M E Ament; H D Ochs
Journal:  N Engl J Med       Date:  1973-02-22       Impact factor: 91.245

3.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 4.  Transforming Growth Factor-β Signaling in Immunity and Cancer.

Authors:  Eduard Batlle; Joan Massagué
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

5.  Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.

Authors:  Giulia Angelino; Paola De Angelis; Simona Faraci; Francesca Rea; Erminia Francesca Romeo; Filippo Torroni; Renato Tambucci; Alessia Claps; Paola Francalanci; Maria Chiriaco; Gigliola Di Matteo; Caterina Cancrini; Paolo Palma; Patrizia D'Argenio; Luigi Dall'Oglio; Paolo Rossi; Andrea Finocchi
Journal:  Pediatr Allergy Immunol       Date:  2017-12       Impact factor: 6.377

6.  New therapeutic approach by sirolimus for enteropathy treatment in patients with LRBA deficiency.

Authors:  G Azizi; H Abolhassani; R Yazdani; S Mohammadikhajehdehi; N Parvaneh; B Negahdari; J Mohammadi; A Aghamohammadi
Journal:  Eur Ann Allergy Clin Immunol       Date:  2017-09

7.  Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.

Authors:  Dominik Aschenbrenner; Maria Quaranta; Stephen N Sansom; Holm H Uhlig; Soumya Banerjee; Nicholas Ilott; Joanneke Jansen; Boyd Steere; Yin-Huai Chen; Stephen Ho; Karen Cox; Carolina V Arancibia-Cárcamo; Mark Coles; Eamonn Gaffney; Simon Pl Travis; Lee Denson; Subra Kugathasan; Jochen Schmitz; Fiona Powrie
Journal:  Gut       Date:  2020-10-09       Impact factor: 23.059

8.  A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease.

Authors:  Gudny A Arnadottir; Gudmundur L Norddahl; Steinunn Gudmundsdottir; Arna B Agustsdottir; Snaevar Sigurdsson; Brynjar O Jensson; Kristbjorg Bjarnadottir; Fannar Theodors; Stefania Benonisdottir; Erna V Ivarsdottir; Asmundur Oddsson; Ragnar P Kristjansson; Gerald Sulem; Kristjan F Alexandersson; Thorhildur Juliusdottir; Kjartan R Gudmundsson; Jona Saemundsdottir; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Sigurdsson; Paolo Manzanillo; Sigurjon A Gudjonsson; Gudmundur A Thorisson; Olafur Th Magnusson; Gisli Masson; Kjartan B Orvar; Hilma Holm; Sigurdur Bjornsson; Reynir Arngrimsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Asgeir Haraldsson; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2018-10-25       Impact factor: 14.919

9.  Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD.

Authors:  Danielle E Arnold; Rofida Nofal; Connor Wakefield; Kai Lehmberg; Katharina Wustrau; Michael H Albert; Emma C Morris; Jennifer R Heimall; Nancy J Bunin; Ashish Kumar; Michael B Jordan; Theresa Cole; Sharon Choo; Tim Brettig; Carsten Speckmann; Stephan Ehl; Malgorzata Salamonowicz; Justin Wahlstrom; Kanchan Rao; Claire Booth; Austen Worth; Rebecca A Marsh
Journal:  J Clin Immunol       Date:  2021-09-29       Impact factor: 8.317

10.  Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.

Authors:  Ahmad A Al-Shaibi; Ussama M Abdel-Motal; Satanay Z Hubrack; Alex N Bullock; Amna A Al-Marri; Nourhen Agrebi; Abdulrahman A Al-Subaiey; Nazira A Ibrahim; Adrian K Charles; Mamoun Elawad; Holm H Uhlig; Bernice Lo
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.